tiprankstipranks
Precision: Partner iECURE announced news from the OTC-HOPE study in January
PremiumThe FlyPrecision: Partner iECURE announced news from the OTC-HOPE study in January
7d ago
Precision BioSciences reports Q4 EPS ($2.22), consensus ($2.94)
Premium
The Fly
Precision BioSciences reports Q4 EPS ($2.22), consensus ($2.94)
7d ago
Precision BioSciences: Promising Gene Editing Advancements and Strategic Positioning in DMD and HBV Markets
Premium
Ratings
Precision BioSciences: Promising Gene Editing Advancements and Strategic Positioning in DMD and HBV Markets
13d ago
Precision BioSciences: Promising Phase 1 Results and Innovative Approach to cHBV Treatment Make It a Compelling Buy
PremiumRatingsPrecision BioSciences: Promising Phase 1 Results and Innovative Approach to cHBV Treatment Make It a Compelling Buy
19d ago
Buy Rating for Precision BioSciences: Promising Clinical Data and Undervaluation Highlight Favorable Risk/Reward Scenario
Premium
Ratings
Buy Rating for Precision BioSciences: Promising Clinical Data and Undervaluation Highlight Favorable Risk/Reward Scenario
1M ago
Encouraging Initial Data for Precision BioSciences’ PBGENE-HBV Supports Positive Analyst Rating and $60 Target Price
Premium
Ratings
Encouraging Initial Data for Precision BioSciences’ PBGENE-HBV Supports Positive Analyst Rating and $60 Target Price
1M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
Precision BioSciences upgraded to Outperform from Market Perform at BMO Capital
Premium
The Fly
Precision BioSciences upgraded to Outperform from Market Perform at BMO Capital
3M ago
Precision BioSciences to present preclinical PBGENE-HBV data
Premium
The Fly
Precision BioSciences to present preclinical PBGENE-HBV data
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100